tiprankstipranks
Trending News
More News >
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
UK Market

Allergy Therapeutics (AGY) Ratios

Compare
16 Followers

Allergy Therapeutics Ratios

GB:AGY's free cash flow for Q2 2024 was £0.61. For the 2024 fiscal year, GB:AGY's free cash flow was decreased by £ and operating cash flow was £-0.25. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
1.63 1.81 2.35 3.17 3.03
Quick Ratio
1.01 1.18 1.72 2.58 2.47
Cash Ratio
0.63 0.80 1.14 2.21 2.03
Solvency Ratio
-0.59 -0.60 -0.27 0.18 0.26
Operating Cash Flow Ratio
-1.56 -1.67 -0.78 0.47 0.67
Short-Term Operating Cash Flow Coverage
-53.56 -47.71 -14.82 8.84 14.81
Net Current Asset Value
£ -27.64M£ -31.18M£ 7.21M£ 18.30M£ 12.73M
Leverage Ratios
Debt-to-Assets Ratio
0.48 0.54 0.14 0.13 0.14
Debt-to-Equity Ratio
8.35 17.42 0.28 0.23 0.28
Debt-to-Capital Ratio
0.89 0.95 0.22 0.19 0.22
Long-Term Debt-to-Capital Ratio
0.86 0.93 0.04 0.05 0.06
Financial Leverage Ratio
17.48 32.32 1.93 1.81 1.97
Debt Service Coverage Ratio
-6.75 -13.08 -6.07 5.49 9.68
Interest Coverage Ratio
-8.58 -16.15 -24.03 6.85 13.15
Debt to Market Cap
0.13 3.85 <0.01 <0.01 <0.01
Interest Debt Per Share
<0.01 0.06 0.02 0.02 0.02
Net Debt to EBITDA
-0.59 -0.58 1.15 -3.83 -2.12
Profitability Margins
Gross Profit Margin
53.87%54.86%67.27%73.28%73.54%
EBIT Margin
-63.51%-66.00%-16.47%4.92%9.94%
EBITDA Margin
-55.69%-60.82%-11.94%9.02%14.95%
Operating Profit Margin
-63.87%-58.49%-17.87%3.13%5.70%
Pretax Profit Margin
-70.95%-71.53%-18.41%3.66%9.51%
Net Profit Margin
-72.86%-72.28%-18.93%3.42%9.03%
Continuous Operations Profit Margin
-72.86%-72.28%-18.93%3.42%9.03%
Net Income Per EBT
102.68%101.05%102.83%93.40%94.90%
EBT Per EBIT
111.09%122.30%103.05%116.91%166.82%
Return on Assets (ROA)
-62.04%-64.51%-18.88%3.28%8.19%
Return on Equity (ROE)
-1084.28%-2084.75%-36.48%5.95%16.12%
Return on Capital Employed (ROCE)
-79.62%-72.30%-23.68%3.78%6.56%
Return on Invested Capital (ROIC)
-78.03%-70.43%-23.39%3.45%6.02%
Return on Tangible Assets
-66.87%-72.97%-21.34%3.61%9.05%
Earnings Yield
-22.86%-612.38%-0.10%0.02%0.08%
Efficiency Ratios
Receivables Turnover
7.06 8.41 6.95 13.55 9.68
Payables Turnover
6.34 6.58 5.56 7.78 9.33
Inventory Turnover
2.00 2.32 2.09 2.08 2.04
Fixed Asset Turnover
2.32 2.56 3.60 4.28 3.83
Asset Turnover
0.85 0.89 1.00 0.96 0.91
Working Capital Turnover Ratio
3.96 3.03 2.28 2.20 2.34
Cash Conversion Cycle
176.86 145.24 161.76 155.56 177.32
Days of Sales Outstanding
51.73 43.42 52.51 26.93 37.69
Days of Inventory Outstanding
182.69 157.33 174.88 175.56 178.74
Days of Payables Outstanding
57.56 55.50 65.63 46.93 39.11
Operating Cycle
234.42 200.74 227.39 202.49 216.44
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 -0.05 -0.02 0.01 0.02
Free Cash Flow Per Share
>-0.01 -0.05 -0.03 <0.01 0.01
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.11 1.15 1.22 0.70 0.79
Dividend Paid and CapEx Coverage Ratio
-9.45 -6.62 -4.62 3.32 4.82
Capital Expenditure Coverage Ratio
-9.45 -6.62 -4.62 3.32 4.82
Operating Cash Flow Coverage Ratio
-1.04 -0.86 -1.34 0.76 1.01
Operating Cash Flow to Sales Ratio
-0.58 -0.52 -0.19 0.10 0.16
Free Cash Flow Yield
-20.20%-505.95%-0.13%0.04%0.10%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-4.37 -0.16 -968.54 5.82K 1.33K
Price-to-Sales (P/S) Ratio
3.19 0.12 183.36 199.01 120.25
Price-to-Book (P/B) Ratio
47.44 3.40 353.31 345.79 214.79
Price-to-Free Cash Flow (P/FCF) Ratio
-4.95 -0.20 -777.22 2.82K 966.59
Price-to-Operating Cash Flow Ratio
-5.47 -0.23 -945.55 1.97K 766.04
Price-to-Earnings Growth (PEG) Ratio
0.05 >-0.01 1.68 -97.80 13.09
Price-to-Fair Value
47.44 3.40 353.31 345.79 214.79
Enterprise Value Multiple
-6.31 -0.78 -1.53K 2.20K 802.39
Enterprise Value
EV to EBITDA
-6.31 -0.78 -1.53K 2.20K 802.39
EV to Sales
3.51 0.47 183.22 198.67 119.93
EV to Free Cash Flow
-5.46 -0.79 -776.64 2.81K 964.04
EV to Operating Cash Flow
-6.04 -0.91 -944.84 1.97K 764.02
Tangible Book Value Per Share
>-0.01 >-0.01 0.05 0.06 0.05
Shareholders’ Equity Per Share
<0.01 <0.01 0.06 0.07 0.07
Tax and Other Ratios
Effective Tax Rate
-0.03 -0.01 -0.03 0.07 0.05
Revenue Per Share
0.01 0.09 0.11 0.13 0.12
Net Income Per Share
-0.01 -0.06 -0.02 <0.01 0.01
Tax Burden
1.03 1.01 1.03 0.93 0.95
Interest Burden
1.12 1.08 1.12 0.74 0.96
Research & Development to Revenue
0.41 0.34 0.22 0.15 0.12
SG&A to Revenue
0.41 0.42 0.29 0.25 0.25
Stock-Based Compensation to Revenue
0.00 <0.01 <0.01 <0.01 0.01
Income Quality
0.80 0.72 1.02 2.95 1.74
Currency in GBP
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis